HC Wainwright Initiates Coverage on Humacyte (NASDAQ:HUMA)
HC Wainwright started coverage on shares of Humacyte (NASDAQ:HUMA – Get Free Report) in a research note issued on Wednesday, MarketBeat.com reports. The firm set a “buy” rating and a $4.00 price target on the stock. HC Wainwright’s price objective points to a potential upside of 111.64% from the stock’s current price. A number of […]
HC Wainwright started coverage on shares of Humacyte (NASDAQ:HUMA – Get Free Report) in a research note issued on Wednesday, MarketBeat.com reports. The firm set a “buy” rating and a $4.00 price target on the stock. HC Wainwright’s price objective points to a potential upside of 111.64% from the stock’s current price. A number of […]
